AN OPEN-LABEL STUDY OF FAMOTIDINE AS A TREATMENT FOR SCHIZOPHRENIA

被引：0
|
作者：
WHITEFORD, HA
STEDMAN, TJ
MCGRATH, JJ
WELHAM, J
POND, S
机构：
来源：
JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 1995年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：239 / 240
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study
    Miyaoka, Tsuyoshi
    Wake, Rei
    Araki, Tomoko
    Inoue, Ken
    Horiguchi, Jun
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 60
  • [22] Ziprasidone in treatment-resistant schizophrenia: A 52-week, open-label continuation study
    Loebel, Antony D.
    Khanna, Surnant
    Rajadhyaksha, Sunita
    Siu, Cynthia O.
    Giller, Earl
    Potkin, Steven G.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (09) : 1333 - 1338
  • [23] GLYCINE ADJUVANT THERAPY TO CONVENTIONAL NEUROLEPTIC TREATMENT IN SCHIZOPHRENIA - AN OPEN-LABEL, PILOT-STUDY
    ROSSE, RB
    THEUT, SK
    BANAYSCHWARTZ, M
    LEIGHTON, M
    SCARCELLA, E
    COHEN, CG
    DEUTSCH, SI
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 416 - 424
  • [24] D-CYCLOSERINE ADJUVANT THERAPY TO CONVENTIONAL NEUROLEPTIC TREATMENT IN SCHIZOPHRENIA - AN OPEN-LABEL STUDY
    CASCELLA, NG
    MACCIARDI, F
    CAVALLINI, C
    SMERALDI, E
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1994, 95 (02) : 105 - 111
  • [25] Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study
    Stryjer, Rafael
    Dambinsky, Yael
    Timinsky, Igor
    Green, Tamar
    Kotler, Moshe
    Weizman, Abraham
    Spivak, Baruch
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (02) : 96 - 98
  • [26] An Open-label Trial of Adjunctive Tocilizumab in Schizophrenia
    Miller, Brian J.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 29S - 29S
  • [27] AN OPEN-LABEL TRIAL OF ADJUNCTIVE TOCILIZUMAB IN SCHIZOPHRENIA
    Miller, Brian J.
    Dias, James
    Buckley, Peter
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S347 - S347
  • [28] AN OPEN-LABEL TRIAL OF ADJUNCTIVE TOCILIZUMAB IN SCHIZOPHRENIA
    Miller, B.
    Dias, J.
    Buckley, P.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [29] Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: An open-label study
    Zalsman, G
    Carmon, E
    Martin, A
    Bensason, D
    Weizman, A
    Tyano, S
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (03) : 319 - 327
  • [30] Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia
    Rosenthal, MH
    Bryant, SL
    CLINICAL NEUROPHARMACOLOGY, 2004, 27 (01) : 38 - 43
12345